Starling Oncology, Inc. (STLNW) cash flow statement

STLNWNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLN

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.03+0.00 (+10.87%)

Close on Oct 30, 2026Market cap $665.51MP/E –Yield –

Starling Oncology, Inc. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q2 2026 2026-06-30	TTM Q1 2026 2026-03-31	TTM FY 2025 2025-12-31	TTM Q3 2025 2025-09-30	TTM Q2 2025 2025-06-30	TTM Q1 2025 2025-03-31	TTM FY 2024 2024-12-31	TTM Q3 2024 2024-09-30	TTM Q2 2024 2024-06-30	TTM Q1 2024 2024-03-31	TTM FY 2023 2023-12-31	TTM Q3 2023 2023-09-30	TTM Q2 2023 2023-06-30	TTM Q1 2023 2023-03-31	TTM FY 2022 2022-12-31	TTM Q3 2022 2022-09-30	TTM Q2 2022 2022-06-30	TTM Q1 2022 2022-03-31	TTM FY 2021 2021-12-31	TTM Q3 2021 2021-09-30	TTM Q2 2021 2021-06-30	TTM Q1 2021 2021-03-31	TTM FY 2020 2020-12-31
Depreciation & Amortization	6.81	6.78	6.94	7.02	6.87	6.58	6.29	6.16	6.28	6.09	5.87	5.49	4.92	4.69	4.41	4.14	3.86	3.55	3.34	–	–	–	–
Stock-Based Compensation	5.10	4.78	4.55	4.52	5.89	8.52	11	14	16	17	18	20	22	24	28	46	40	33	25	–	–	–	–
Deferred Income Taxes	–	–	-0.03	–	–	–	0	-0.13	-0.05	-0.05	-0.08	-0.40	-0.42	-0.47	-0.26	2.48	-1.33	-1.28	-1.24	–	–	–	–
Change in Accounts Receivable	-11	-10	-12	-6.78	-3.29	9.44	-5.98	-8.05	-9.65	-15	-4.56	-14	-18	-22	-20	-13	-9.60	-6.31	-2.20	–	–	–	–
Change in Inventory	-4.23	-12	-6.84	-8.78	-4.46	-0.75	3.64	2.10	0.88	-1.27	-4.39	-2.06	-2.91	-1.39	-1.73	-3.09	-3.30	-3.18	-1.84	–	–	–	–
Change in Accounts Payable	25	19	20	13	20	7.92	9.22	9.57	2.20	8.84	5.06	2.18	-0.78	-0.65	-6.19	-7.74	0.31	-0.52	2.92	10	–	–	3.76
Operating Cash Flow	0.33	-22	-25	-24	-10	-16	-27	-35	-44	-37	-36	-46	-59	-60	-62	-71	-53	-50	-33	-8.34	-5.73	1.00	0.51
Capital Expenditures	-3.61	-3.91	-3.20	-3.90	-2.89	-3.51	-3.79	-2.90	-4.23	-3.34	-4.57	-5.70	-5.96	-6.37	-5.53	-4.41	-4.17	-3.23	-2.85	–	–	–	–
Acquisitions	–	–	–	–	–	–	0	–	–	–	-4.46	–	–	–	-8.58	-16	-17	-8.28	-9.11	–	–	–	–
Sale of Property, Plant & Equipment	0	0	0.13	0.13	0.13	0.13	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Purchase of Investments	–	–	–	–	–	–	0	0.09	0.15	0.16	-9.60	-40	-127	-127	-118	-87	–	–	0	–	–	–	–
Sale & Maturity of Investments	–	–	0	0	10	30	50	63	61	71	81	69	60	30	0	–	–	–	–	–	–	–	–
Investing Cash Flow	-3.61	-3.91	-3.07	-3.77	7.24	27	46	60	57	64	63	18	-77	-112	-132	-108	-21	-12	-12	218	219	220	-8.84
Share Repurchases	–	–	–	–	–	–	0	–	–	–	-1.02	–	–	–	-9.00	–	–	–	0	–	–	–	–
Stock Issued	–	–	14	9.95	2.27	0.06	0	0.11	0.20	0.20	0.13	–	–	–	–	–	–	–	–	–	–	–	–
Debt Issued	–	–	–	–	–	–	–	–	–	–	0	–	–	–	110	–	–	–	0	–	–	–	–
Debt Repaid	0	0	-20	-20	-20	-20	0	–	–	–	–	–	–	–	0	-5.13	-5.13	-7.13	-7.22	–	–	–	–
Taxes Paid on Share-Based Awards	–	–	–	–	–	–	–	–	–	–	0	–	–	–	-0.41	–	–	–	0	–	–	–	–
Financing Cash Flow	14	16	12	7.66	-3.18	-7.29	-3.49	-5.11	-5.62	-6.08	-6.85	-5.91	100	92	92	229	124	130	154	-202	-202	-197	12
Free Cash Flow	-3.29	-26	-28	-28	-13	-19	-30	-38	-48	-40	-41	-52	-64	-67	-67	-75	-58	-53	-36	–	–	–	–
Income Taxes Paid	–	–	–	–	–	–	0	0.18	0.23	0.34	0.40	0.35	0.30	0.22	0.15	1.32	1.50	1.72	1.73	–	–	–	–
Interest Paid	3.51	3.51	3.91	4.20	4.43	4.65	4.50	4.46	4.48	4.51	4.51	3.42	2.34	1.28	0.22	0.27	0.27	0.35	0.28	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -4.4%
Net margin: -6.2%
Return on equity, FY2025: 999.2%

Financial strength

Current ratio: 1.36
Debt to equity: -3.21
Debt to assets: 44.8%
Cash to current liabilities: 43.3%

Valuation

P/E ratio: –
Price to sales: 1.13
Price to book: –
Dividend yield: –